NCT01594801View on ClinicalTrials.gov

Testing the Effect of the InsuPad Device in Daily Life Conditions

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Diabetics Mellitus Type 1Diabetes Mellitus Type 2
Interventions
DEVICE

InsuPad

Use of the InsuPad for at least 3 times a day.

Trial Locations (9)

10115

ikfe GmbH, Berlin, Berlin

14469

ikfe GmbH, Potsdam, Potsdam

14471

Dr. Notghi Clinical Trials, Potsdam

55116

ikfe GmbH Mainz, Mainz

56564

Zentrum Für Klinische Studien Neuwied, Neuwied

63739

Gemeinschaftspraxis Dr. Klausmann/ Dr. Welslau, Aschaffenburg

67714

Allgemeinärztliche Berufsausübungs-gemeinschaft Waldfischbach-Burgalben, Waldfischbach-Burgalben

Unknown

Diabeteszentrum Bad Mergentheim, Bad Mergentheim

01307

GWT-TUD GmbH, Zentrum für Klinische Studien, Dresden

Sponsors
All Listed Sponsors
lead

Insuline Medical Ltd.

INDUSTRY